Sunday, March 30, 2008

Lead Vytorin researcher on benefit of Schering-Plough drug: "Zilch"

The results show the drug had "no result — zilch. In no subgroup, in no segment, was there any added benefit" in terms of reducing plaque, said Dr. John Kastelein, the Dutch scientist who led the study.


No comments: